Home » Drug Information » Recently Approved Drugs » 1996
Medical Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Schering-Plough
Approval Status: Approved October 1996
Treatment Area: seasonal allergies in children
Claritin Syrup has been approved as a non-drowsy antihistamine
syrup for children as young as six years of age. In addition, the
indication for Claritin tablets was expanded to include children
age six years and up.
Available only by prescription in a once-daily formula, Claritin
Syrup is indicated for the treatment of allergy symptoms, including
itchy, watery eyes; runny nose; itchy palate; sneezing; and
idiopathic chronic urticaria (hives).
Claritin Syrup, in an alcohol-free and dye-free fruit flavored
formula, is administered orally at a dose of two teaspoons
once-per-day for children as young as six years of age.
In controlled clinical trials using the recommended dose, the
incidence of the most commonly reported adverse events was
comparable to placebo.
